Preimplantation Genetic Testing for Aneuploidy (PGT-A) on Blastocyst Quality, Vitrification Timing, and IVF Outcomes: A Comparative Study
Research Article


DOI:
https://doi.org/10.58372/2835-6276.1312Keywords:
Preimplantation Genetic Testing- Aneuploidy, Controls, Blastocyst, TrophectodermAbstract
Background: Preimplantation genetic testing for aneuploidy (PGT-A) is increasingly applied in assisted reproductive technologies, particularly among individuals with advanced maternal age or a history of recurrent pregnancy loss. By enabling the selection of chromosomally normal embryos, PGT-A may improve implantation rates and pregnancy outcomes following the initial embryo transfer. This study aims to compare ICSI outcomes, blastocyst quality, and vitrification timing between PGT-A and control groups to assess the reproductive outcomes
Methods: A retrospective cohort study was conducted at a MHRT Hospital and Research Center, Hyderabad, involving patients undergoing Intracytoplasmic Sperm Injection (ICSI) cycles between March 2022 and March 2025. The study included 52 PGT-A and 52 control patients, with Baseline characteristics, embryological parameters, blastocyst quality, vitrification timing, and reproductive outcomes were assessed. The PGT-A group included embryos that underwent aneuploidy testing via trophectoderm biopsy. Blastocyst expansion, inner cell mass (ICM) quality, trophectoderm (TE) grading, and vitrification day were compared between the two groups.
Results: Patients in the PGT-A group were older and had higher rates of primary and female-factor infertility. Hormonal profiles and oocyte retrieval outcomes were comparable between groups. The PGT-A group was older (mean age 36.2 vs. 33.7 years) and had higher proportions of primary infertility (71.15% vs. 59.61%) and female infertility (61.53% vs. 42.3%). Both groups had more or less similar oocyte retrieval numbers, but the Control group had more prior ICSI cycles. Regarding blastocyst quality, the PGT-A group exhibited higher proportions of grade 3 and grade 6 blastocysts, with a better ICM grade (B) and TE grade (A). The Control group had a higher proportion of grade 4 blastocysts. Additionally, more embryos in the Control group were vitrified on Day 5 (76.92% vs. 61.53%), while the PGT-A group showed a higher proportion vitrified on Day 6 (38.46% vs. 23.07%), these differences did not translate into superior clinical outcomes. The cumulative live-birth rate was slightly lower in the PGT-A group (75%) compared to controls (83.69%). Secondary outcomes, including biochemical, clinical, and ongoing pregnancy rates, were also lower in the PGT-A group. Singleton and twin birth weights were marginally reduced in the PGT-A cohort.
Conclusion: PGT-A is associated with higher-quality blastocysts, particularly in terms of ICM and TE grading. It also influences vitrification strategies, with PGT-A embryos more likely to be vitrified on Day 6. These findings suggest that PGT-A may improve embryo quality, potentially enhancing ICSI outcomes, especially in older women or those with recurrent implantation failure. However, further studies are necessary to refine patient selection criteria and evaluate cost-effectiveness and ethical concerns associated with PGT-A.
References
Retzloff MG, Hornstein MD. Is intracytoplasmic sperm injection safe?. Fertility and sterility. 2003 Oct 1;80(4):851-9.
Babariya D, Fragouli E, Alfarawati S, Spath K, Wells D. The incidence and origin of segmental aneuploidy in human oocytes and preimplantation embryos. Human Reproduction. 2017 Dec 1;32(12):2549-60.
Viotti M. Preimplantation genetic testing for chromosomal abnormalities: aneuploidy, mosaicism, and structural rearrangements. Genes. 2020 May 29;11(6):602.
Morales C. Current applications and controversies in preimplantation genetic testing for aneuploidies (PGT-A) in in vitro fertilization. Reproductive Sciences. 2024 Jan;31(1):66-80.
Stern HJ. Preimplantation genetic diagnosis: prenatal testing for embryos finally achieving its potential. Journal of clinical medicine. 2014 Mar 17;3(1):280-309.
Anderson RE, Whitney JB, Schiewe MC. Clinical benefits of preimplantation genetic testing for aneuploidy (PGT-A) for all in vitro fertilization treatment cycles. European journal of medical genetics. 2020 Feb 1;63(2):103731.
Salame AA, Dahdouh EM, Aljafari R, Samuel DA, Koodathingal BP, Bajpai A, Kainoth S, Fakih M. Predictive factors of aneuploidy in infertile patients undergoing IVF: a retrospective analysis in a private IVF practice. Middle East Fertility Society Journal. 2024 Feb 23;29(1):12.
Yan J, Qin Y, Zhao H, Sun Y, Gong F, Li R, Sun X, Ling X, Li H, Hao C, Tan J. Live birth with or without preimplantation genetic testing for aneuploidy. New England Journal of Medicine. 2021 Nov 25;385(22):2047-58.
Mikwar M, MacFarlane AJ, Marchetti F. Mechanisms of oocyte aneuploidy associated with advanced maternal age. Mutation Research/Reviews in Mutation Research. 2020 Jul 1;785:108320.
Guo L, Li X, Guo A, Wang Y, Liang Y, Li Y, Xu X, Lv H. Comparative study on pregnancy complications: PGT-A vs. IVF-ET with gender-specific outcomes. Frontiers in Endocrinology. 2024 Nov 6;15:1453083.
Munné S, Wells D. Detection of mosaicism at blastocyst stage with the use of high-resolution next-generation sequencing. Fertility and sterility. 2017 May 1;107(5):1085-91.
Zhao J, Yan Y, Huang X, Sun L, Li Y. Blastocoele expansion: an important parameter for predicting clinical success pregnancy after frozen-warmed blastocysts transfer. Reproductive Biology and Endocrinology. 2019 Dec;17:1-8.
Fragouli E, Alfarawati S, Spath K, Wells D. Morphological and cytogenetic assessment of cleavage and blastocyst stage embryos. Molecular human reproduction. 2014 Feb 1;20(2):117-26.
Fragouli E, Wells D. Aneuploidy in the human blastocyst. Cytogenetic and genome research. 2011 Jan 19;133(2-4):149-59.
Sanders KD. Novel Insights into Preimplantation Genetic Testing for Aneuploidy and Non-invasive Prenatal Testing. University of Kent (United Kingdom); 2020.
Sordia-Hernandez, L.H., Morales-Martinez, F.A., González-Colmenero, F.D., Flores Rodriguez, A., Leyva-Camacho, P.C., Sordia-Piñeyro, M.O., Valdés-Martínez, O.H., García-Luna, S.M., Rodríguez-Guajardo, R. and Sordia-Piñeyro, L.H., 2022. The effects of preimplantation genetic testing for aneuploidy (PGT-A) on patient-important outcomes in embryo transfer cases: a meta-analysis. Journal of Reproduction & Infertility, 23(4), p.231.
Wu CQ, Campbell M, Shmorgun D, Torrance S, Gale J, Leveille MC. Comparative embryo development outcomes following extending embryo culture to day 6: a retrospective cohort study. International Journal of Fertility & Sterility. 2022 Dec 25;17(1):40.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 American Journal of Medical and Clinical Research & Reviews

This work is licensed under a Creative Commons Attribution 4.0 International License.